NCT02431481View on ClinicalTrials.gov

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 23, 2015

Primary Completion Date

September 14, 2017

Study Completion Date

May 11, 2018

Conditions
Normal Renal FunctionImpaired Renal Function
Interventions
DRUG

LEE011

400 mg

Trial Locations (4)

1612

Novartis Investigative Site, Sofia

14050

Novartis Investigative Site, Berlin

55404

DaVita Clinical Research, Minneapolis

140 59

Novartis Investigative Site, Prague

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY